ml 9 has been researched along with kt 5823 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forough, R; Granger, HJ; Meininger, CJ; Steinle, JJ; Wu, G; Wu, MH | 1 |
| Bain, J; Cohen, P; Elliott, M; McLauchlan, H | 1 |
| Iida, H; Inoue, N; Ishida, H; Ishikawa, Y; Yuan, Z | 1 |
3 other study(ies) available for ml 9 and kt 5823
| Article | Year |
|---|---|
Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway.
Topics: Alkaloids; Azepines; Blotting, Western; Calcium; Carbazoles; Cell Division; Cell Movement; Cells, Cultured; Chromones; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Humans; Indoles; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microcirculation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Morpholines; Neovascularization, Pathologic; Nitric Oxide; Nitrites; Phosphatidylinositol 3-Kinases; Phosphorylation; Precipitin Tests; Receptor, EphB4; Signal Transduction; Time Factors | 2002 |
The specificities of protein kinase inhibitors: an update.
Topics: Alkaloids; Anthracenes; Azepines; Benzazepines; Carbazoles; Catechin; Cyclin-Dependent Kinases; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Indoles; JNK Mitogen-Activated Protein Kinases; Kinetin; Mitogen-Activated Protein Kinases; Naphthalenes; Oximes; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Signal Transduction; src-Family Kinases; Substrate Specificity | 2003 |
Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Topics: Alkaloids; Amylases; Animals; Azepines; Benzoates; Benzylamines; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Carbazoles; Chelating Agents; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Estrenes; Gallic Acid; Genotype; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Indoles; Male; Mice; Mice, Knockout; Molsidomine; Muscarinic Agonists; Myosin-Light-Chain Kinase; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxadiazoles; Parotid Gland; Penicillamine; Phosphodiesterase Inhibitors; Pilocarpine; Protein Kinase Inhibitors; Pyrroles; Pyrrolidinones; Quinoxalines; Quinuclidines; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Type C Phospholipases | 2003 |